Health ❯ Medicine

Patient Care

Quality of Life Treatment Options Medication Adherence Post-Operative Care Treatment Outcomes Treatment Efficacy Rehabilitation Cancer Treatment Cancer Patients Personalized Medicine

Daraxonrasib Doubles Survival in Phase 3 Trial of Treated Metastatic Pancreatic Cancer

An oral KRAS inhibitor that raised median survival to 13.2 months is now available through an FDA expanded access program pending formal review

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Real-World Study Finds Tezepelumab Cuts Severe Asthma Flares by 70% Across Diverse Patients

Roche Starts Placebo-Controlled Phase 3 Trial of Elevidys to Pursue EU Approval

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Scientific Review Flags He Shou Wu as Multi-Pathway Candidate for Androgenetic Alopecia

Columbia Study Pinpoints How Some Statins May Trigger Muscle Pain

Northwestern Team Keeps Man Alive 48 Hours Without Lungs Before Double Transplant

Brazil Authorizes First Human Trial of UFRJ’s Polilaminina for Acute Spinal Cord Injury

Argentina Launches Lilly’s Mounjaro for Obesity and Diabetes After ANMAT Approval

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

Approved Lymphoma Drug Helps Overcome Resistance in Neuroblastoma Models

EMA Panel Backs Waskyra Gene Therapy for Wiskott‑Aldrich Syndrome

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

HSF1-Driven Autophagy Found to Undercut Proteasome Drugs in AML, Preclinical Combo Shows Benefit

Endoxifen Add-On Restores Tamoxifen Levels in Poor Metabolizers, Phase 1/2 Trial Finds

Regeneron’s Garetosmab Slashes New Bone Lesions in FOP Phase 3, U.S. Filing Planned This Year

Study Links THC in Ovarian Follicles to Lower Rate of Normal Embryos in IVF

King’s Spin-out Targets Human Trials for Oral Cancer Drug After Promising Mouse Results